On July 15, 2025, Judge Evelyn Padin of the District of New Jersey denied Novartis’s motion for preliminary injunction, which would have blocked MSN Laboratories Pvt. Ltd. from selling a generic version of Novartis’s Entresto based on alleged trade dress infringement. Her decision could have significant implications for trade dress claims in the pharmaceutical context....
By: Axinn, Veltrop & Harkrider LLP
http://dlvr.it/TMRJ9Y